181 related articles for article (PubMed ID: 38793661)
1. Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission.
Pighi C; Rotili A; De Luca M; Chiurchiù S; Calò Carducci FI; Rossetti C; Cifaldi L; Bei R; Caforio L; Bernardi S; Palma P; Amodio D
Viruses; 2024 May; 16(5):. PubMed ID: 38793661
[TBL] [Abstract][Full Text] [Related]
2. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
[TBL] [Abstract][Full Text] [Related]
5. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
6. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.
Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y
Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216
[TBL] [Abstract][Full Text] [Related]
7. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
8. Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C
Nerreter T; Zeiß S; Herrmann T; Einsele H; Seggewiss-Bernhardt R
Immunobiology; 2017 May; 222(5):719-725. PubMed ID: 28139257
[TBL] [Abstract][Full Text] [Related]
9. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
11. Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.
Yawata N; Shirane M; Woon K; Lim X; Tanaka H; Kawano YI; Yawata M; Chee SP; Siak J; Sonoda KH
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807229
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence.
Ferron E; David G; Willem C; Legrand N; Salameh P; Anquetil L; Walencik A; Gendzekhadze K; Gagne K; Retière C
Front Immunol; 2024; 15():1389358. PubMed ID: 38736873
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS
J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.
Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D
Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
[TBL] [Abstract][Full Text] [Related]
17. Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection.
Björkström NK; Svensson A; Malmberg KJ; Eriksson K; Ljunggren HG
PLoS One; 2011; 6(11):e27664. PubMed ID: 22110712
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
[TBL] [Abstract][Full Text] [Related]
19. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
20. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
